Learn More
Medchemexpress LLC Repaglinide-d5 | 1217709-85-7 | C27H31D5N2O4 | 25 MG

Supplier: Medchemexpress LLC 25MGHY15209S
Repaglinide-d5 is a deuterium-labeled variant of Repaglinide. Repaglinide acts as an insulin secretagogue, primarily used in the treatment of type-2 diabetes mellitus. It functions by enhancing the early phase of insulin secretion and increasing the overall amount of insulin released, which helps to reduce postprandial glucose levels.
- Used as a tracer.
- Serves as an internal standard for quantitative analysis using techniques such as NMR, GC-MS, or LC-MS.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.